CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Enterprise Value (2023 - 2026)

Updated

CytoMed Therapeutics' Enterprise Value was $14.54 million in Q4 2025, down 59.1% from $35.58 million a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Enterprise Value (2023 - 2026) Analysis & Trends

For FY2025, Enterprise Value at CytoMed Therapeutics came in at $14.56 million, down 59.1% from FY2024.

  • In earlier years, Enterprise Value was $35.59 million in FY2024 (-28.6%) and $49.85 million in FY2023.
  • The Q4 2025 figure marks the lowest quarterly Enterprise Value since Q2 2023.
  • Compared with a year earlier, Enterprise Value was higher in two of the last four quarters, with an average decline of 5.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.15 Mn
Dec 31, 2025 14.54 Mn
Jun 30, 2025 23.19 Mn
Dec 31, 2024 35.58 Mn
Jun 30, 2024 15.01 Mn
Dec 31, 2023 49.88 Mn
Jun 30, 2023 13.70 Mn
API Access

CytoMed Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=GDTC&period=max&api_key=YOUR_API_KEY